Sign inGet started

KELLERMAN DONALD J

Insider CIK 1145911 · MAPP SVP,Clinical Dev & Med Affairs · TNXP See Remarks · ZSAN VP, Clinical Dev & Med Affairs

Track record PRO

XXXX$█.██M██+██%
XXXX$█.██M██+██%
XXXX$█.██M██+██%
Track record
See how this insider's past purchases performed 30 and 90 days later, and a conviction score on each buy.
Upgrade to Pro · $99/yearAlready Pro? Log in

Trades across companies

TickerCodeTradeFiledSharesPriceValueOwned after
ZSAN Zosano Pharma Corp S Sale2022-03-312022-04-014,006$0.21 $84156,331SEC↗
ZSAN Zosano Pharma Corp A Award deriv2021-10-152021-10-1920,000— $020,000SEC↗
ZSAN Zosano Pharma Corp A Award2021-10-152021-10-1910,000— $060,337SEC↗
ZSAN Zosano Pharma Corp S Sale2021-06-042021-06-071,709$0.81 $1.4K50,337SEC↗
ZSAN Zosano Pharma Corp A Award deriv2021-03-302021-04-0165,000— $065,000SEC↗
ZSAN Zosano Pharma Corp A Award2021-03-302021-04-0132,500— $052,046SEC↗
ZSAN Zosano Pharma Corp A Award2020-06-252020-06-2918,750— $019,546SEC↗
ZSAN Zosano Pharma Corp A Award deriv2020-06-032020-06-0537,500— $037,500SEC↗
ZSAN Zosano Pharma Corp A Award deriv2019-06-112019-06-1330,000— $030,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2019-06-112019-06-1930,000— $030,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2018-05-312018-06-01100,000— $0100,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2017-05-312018-04-27180,000— $0180,000SEC↗
ZSAN Zosano Pharma Corp A Award deriv2017-04-102017-04-1215,000— $015,000SEC↗
ZSAN Zosano Pharma Corp P Buy deriv2016-08-192016-08-2215,920$0.13 $2.1K15,920SEC↗
ZSAN Zosano Pharma Corp P Buy deriv2016-08-192016-08-2215,920$0.13 $2.1K15,920SEC↗
ZSAN Zosano Pharma Corp P Buy2016-08-192016-08-2215,920$1.32 $21.0K15,920SEC↗
TNXP Tonix Pharmaceuticals Hold A Award deriv2014-10-292014-11-0336,000— $036,000SEC↗
TNXP Tonix Pharmaceuticals Hold A Award deriv2014-06-172014-06-2036,000— $036,000SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0427,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-044,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0432,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-048,250— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0455,000— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0429,500— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. D To issuer deriv2013-03-012013-03-0461,450— $00SEC↗
MAPP MAP Pharmaceuticals, Inc. U Tender2013-03-012013-03-043,795$25.00 $94.9K0SEC↗
MAPP MAP Pharmaceuticals, Inc. S Sale2013-02-012013-02-041,429$24.73 $35.3K3,479SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-262013-01-292,250— $04,500SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2013-01-262013-01-29871$24.75 $21.6K4,908SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-262013-01-292,250— $05,779SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2013-01-252013-01-292,750— $08,250SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2013-01-252013-01-291,207$24.75 $29.9K3,529SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2013-01-252013-01-292,750— $04,736SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise deriv2012-01-262012-01-272,250— $06,750SEC↗
MAPP MAP Pharmaceuticals, Inc. M Exercise2012-01-262012-01-272,250— $02,372SEC↗
MAPP MAP Pharmaceuticals, Inc. F Tax w/h2012-01-262012-01-27943$13.84 $13.1K1,429SEC↗
MAPP MAP Pharmaceuticals, Inc. A Award deriv2012-01-252012-01-2732,500— $032,500SEC↗
MAPP MAP Pharmaceuticals, Inc. A Award deriv2012-01-252012-01-2711,000— $011,000SEC↗